ABTABBOTT LABORATORIESvs its industry peers
A metric-by-metric comparison of ABBOTT LABORATORIES against Health Care Select Sector SPDR Fund holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABT본 종목 | $186.9B#8 | 30.1x#7 | 3.6x#3 | 4.2x#5 | 5.7%#10 | -51.3%#16 | 18.2%#12 | 12.5%#12 | 8.3%#13 | — | -14.4%#12 | 2.2%#7 |
| LLY | $1.15T#1 | 43.4x#15 | 36.9x#14 | 17.7x#16 | 44.7%#1 | 94.9%#4 | 40.2%#1 | 66.2%#2 | 30.4%#2 | — | 60.8%#4 | 0.5%#12 |
| JNJ | $642.7B#2 | 30.9x#8 | 7.6x#10 | 6.8x#12 | 6.0%#9 | 90.6%#5 | 22.9%#8 | 31.5%#7 | 16.1%#8 | 6#4 | 61.6%#3 | 1.9%#9 |
| ABBV | $464.9B#3 | 129.6x#16 | — | 7.6x#13 | 8.6%#8 | -1.2%#12 | 24.6%#7 | — | 20.0%#6 | — | 41.0%#5 | 2.5%#4 |
| MRK | $325.6B#5 | 37.1x#12 | 7.1x#9 | 5.0x#7 | 1.3%#14 | 6.6%#10 | 34.2%#3 | 39.8%#3 | 21.5%#5 | — | 63.4%#2 | 2.5%#3 |
| UNH | $389.5B#4 | 32.3x#10 | 11.8x#12 | 0.9x#2 | 11.8%#4 | -16.3%#15 | 4.2%#15 | 36.5%#4 | 19.9%#7 | — | 67.4%#1 | 2.0%#8 |
| AMGN | $212.1B#7 | 27.4x#5 | 23.1x#13 | 5.8x#11 | 10.0%#6 | 88.5%#6 | 24.7%#6 | 83.9%#1 | 15.3%#9 | — | 32.7%#7 | 2.4%#5 |
| TMO | $214.2B#6 | 31.7x#9 | 4.1x#4 | 4.8x#6 | 3.9%#11 | 6.0%#11 | 17.4%#13 | 12.9%#11 | 10.1%#12 | — | 19.8%#9 | 0.3%#14 |
| GILD | $166.8B#9 | 18.3x#2 | 7.1x#8 | 5.7x#9 | 2.4%#13 | 1672.9%#1 | 34.0%#4 | 36.2%#5 | 21.6%#4 | — | 20.4%#8 | 2.4%#6 |
| ISRG | $127.9B#14 | 41.5x#14 | 7.0x#7 | 12.7x#15 | 20.5%#2 | 23.0%#8 | 29.3%#5 | 15.7%#10 | — | — | -27.2%#13 | — |
| PFE | $144.0B#10 | 19.3x#3 | 1.6x#1 | 2.3x#3 | -1.6%#16 | -3.2%#13 | 16.3%#14 | 8.6%#13 | 6.7%#14 | — | 11.0%#10 | 6.8%#1 |
| BMY | $129.9B#13 | 17.8x#1 | 6.5x#6 | 2.7x#4 | -0.2%#15 | 178.8%#3 | 21.8%#9 | 35.2%#6 | 14.4%#11 | 8#1 | 41.0%#6 | 3.9%#2 |
| DHR | $140.0B#11 | 35.4x#11 | 2.7x#2 | 5.7x#10 | 2.9%#12 | -7.3%#14 | 19.1%#11 | 6.9%#14 | 5.4%#15 | 5#5 | — | 0.6%#11 |
| VRTX | $124.5B#15 | 29.1x#6 | 6.4x#5 | 10.4x#14 | 8.9%#7 | 838.1%#2 | 34.8%#2 | 20.4%#9 | 25.4%#3 | — | 4.6%#11 | — |
| SYK | $132.9B#12 | 40.1x#13 | 11.3x#11 | 5.3x#8 | 11.2%#5 | 8.5%#9 | 19.5%#10 | 27.7%#8 | 14.9%#10 | 8#1 | — | 1.0%#10 |
| MCK | $106.9B#16 | 23.2x#4 | — | 0.3x#1 | 12.4%#3 | 44.5%#7 | 1.5%#16 | — | 284.4%#1 | 7#3 | — | 0.4%#13 |
Peer set: top holdings of XLV (Health Care Select Sector SPDR Fund), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-07-29.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice